With few exceptions, the most commonly recommended triple Helicobacter pylori regimen
(proton pump inhibitor (PPI), amoxicillin and clarithromycin) now provides unacceptably low …

Background: Guidelines on the management of Helicobacter pylori, which cover indications
for management and treatment strategies, were produced in 2000. Aims: To update the …

Background & Aims A number of double, triple, and quadruple therapies have been
proposed as first-line empiric treatments for Helicobacter pylori infection. However …

Helicobacter pylori (H. pylori) remains a prevalent, worldwide, chronic infection. Though the
prevalence of this infection appears to be decreasing in many parts of the world, H. pylori …

Objective To do a systematic review and meta-analysis of studies comparing sequential
therapy for eradication of Helicobacter pylori with pre-existing and new therapies, thus …

Helicobacter pylori causes a serious bacterial infectious disease, and the expectations of
therapy should reflect this fact. Increasing antibiotic resistance, especially to clarithromycin …

Helicobacter pylori (H. pylori) infection is highly associated with the occurrence of
gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric cancer, and …

The main challenge in the field of Helicobacter pylori (H. pylori) infection is antibiotic
resistance, which influences the efficacy of eradication regimens. Bismuth-containing …

Background: Antimicrobial resistance has decreased eradication rates for Helicobacter
pylori infection worldwide. Objective: To determine whether sequential treatment eradicates …

OBJECTIVES: Eradication rates with triple therapy (TT) forHelicobacter pyloriinfection have
declined to unacceptable levels. Sequential therapy (ST) is a novel treatment that has …